脊髓切除术作为内皮移植后移植拒绝的危险因素:回顾性研究
Paola Kammrath Betancor1, Daniel Böhringer1, Philip Maier1
1Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Interactive journal of medical research
|September 10, 2024
概括
切除术似乎不会显著影响Descemet膜内皮质角质形成手术 (DMEK) 后的结果. 这表明前腔相关免疫偏差 (ACAID) 可能不是DMEK或脏中有利结果的主要驱动因素.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
背景情况:
- 前腔相关免疫偏差 (ACAID) 是前眼腔抗原暴露引起的活性免疫耐受性机制,对于Descemet膜内皮质角质成形 (DMEK) 的良好结果至关重要.
- 动物模型表明,功能性脏对于ACAID发育至关重要.
研究的目的:
- 研究切除术对DMEK后人类患者排斥率的影响.
- 为了确定脏在ACAID中的作用是否会影响人类的DMEK移植存活率.
主要方法:
- 在单一中心对DMEK患者结果的回顾性分析.
- 在有和没有脊髓切除病史的患者之间比较移植存活率和免疫反应.
- 通过邮寄问卷收集数据,并审查医疗记录.
主要成果:
- 在1340名DMEK患者中,16名 (1.2%) 报告了脊髓切除术.
- 脊髓切除组 (26只眼睛) 需要第二次移植的比例为19% (脱位,失败,拒绝).
- 卡普兰-梅尔分析显示,在脊髓切除术患者和对照人群之间,移植结果没有显著差异.
结论:
- 切除术似乎不会对DMEK结果产生重大影响.
- 在DMEK中,ACAID可能不是有利免疫结果的主要机制,或者脏的作用在人类中不那么重要.
- 脊髓切除术患者的样本规模很小,因此在解释小效应可能性时需要谨慎.
更多相关视频
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
159
02:09Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
Published on: December 20, 2024
209
相关概念视频
01:22Bone Marrow Sampling and Transplants
316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316
01:24Tissue Transplantation
343
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
343